BIVI Form 3 shows director with no beneficial ownership

Rhea-AI Filing Summary

BioVie Inc. (BIVI) filed a Form 3, the initial statement of beneficial ownership for a board member. The reporting person is a Director, and the filing states that no securities are beneficially owned as of the event date 07/17/2025. The form indicates it was filed by one reporting person. This is a routine ownership disclosure that establishes the insider’s baseline holdings at the time of becoming subject to reporting.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Farag Kameel D.

(Last) (First) (Middle)

C/O BIOVIE INC.

680 W NYE LANE STE. 201

(Street)

CARSON CITY NV 89703

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/17/2025

3. Issuer Name and Ticker or Trading Symbol
BIOVIE INC. [ BIVI ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Joanne Wendy Kim, attorney-in-fact for Kameel D. Farag	10/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did BioVie (BIVI) disclose in this Form 3?

The filing reports that a Director has no securities beneficially owned as of 07/17/2025.

Who is the reporting person on the BIVI Form 3?

The signature indicates filing by Joanne Wendy Kim, attorney-in-fact for Kameel D. Farag.

What is the relationship of the reporting person to BioVie (BIVI)?

The reporting person is a Director.

How many reporting persons are included in this filing?

It is filed by one reporting person.

What is the event date for the holdings reported?

The event date is 07/17/2025.

Does the Form 3 list any derivative or non-derivative holdings?

No. The filing states: “No securities are beneficially owned.”